Cargando…
Parkinson’s disease laterality: a (11)C-PE2I PET imaging study
Asymmetry of striatal dopaminergic deficits and motor symptoms is a typical characteristic of idiopathic Parkinson’s disease (PD). This study aims to characterise the trend of asymmetry in moderate-stage PD. We performed a 19-month longitudinal study in 27 patients with PET-CT imaging and appropriat...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880931/ https://www.ncbi.nlm.nih.gov/pubmed/32880071 http://dx.doi.org/10.1007/s00415-020-10204-y |
_version_ | 1783650771391217664 |
---|---|
author | Roussakis, Andreas-Antonios Zeng, Zhou Lao-Kaim, Nicholas P. Martin-Bastida, Antonio Piccini, Paola |
author_facet | Roussakis, Andreas-Antonios Zeng, Zhou Lao-Kaim, Nicholas P. Martin-Bastida, Antonio Piccini, Paola |
author_sort | Roussakis, Andreas-Antonios |
collection | PubMed |
description | Asymmetry of striatal dopaminergic deficits and motor symptoms is a typical characteristic of idiopathic Parkinson’s disease (PD). This study aims to characterise the trend of asymmetry in moderate-stage PD. We performed a 19-month longitudinal study in 27 patients with PET-CT imaging and appropriate clinical assessments. (11)C-PE2I non-displaceable binding potential (BP(ND)) was calculated bilaterally for the striatum at baseline and follow-up to estimate the in vivo density of striatal dopamine transporters (DAT). Changes in striatal (11)C-PE2I BP(ND) over time were more prominent in the ipsilateral as compared to contralateral side. Changes in MDS-UPDRS-III (motor component of the Movement Disorders Society Unified PD Rating Scale) were not different between the clinically most and least affected body sides. Our data support that the asymmetry in striatal dopaminergic degeneration becomes less prominent in moderate-stage PD. In contrast, during the above period, the asymmetry of motor symptoms was maintained between the clinically most and least affected body sides. |
format | Online Article Text |
id | pubmed-7880931 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-78809312021-02-18 Parkinson’s disease laterality: a (11)C-PE2I PET imaging study Roussakis, Andreas-Antonios Zeng, Zhou Lao-Kaim, Nicholas P. Martin-Bastida, Antonio Piccini, Paola J Neurol Original Communication Asymmetry of striatal dopaminergic deficits and motor symptoms is a typical characteristic of idiopathic Parkinson’s disease (PD). This study aims to characterise the trend of asymmetry in moderate-stage PD. We performed a 19-month longitudinal study in 27 patients with PET-CT imaging and appropriate clinical assessments. (11)C-PE2I non-displaceable binding potential (BP(ND)) was calculated bilaterally for the striatum at baseline and follow-up to estimate the in vivo density of striatal dopamine transporters (DAT). Changes in striatal (11)C-PE2I BP(ND) over time were more prominent in the ipsilateral as compared to contralateral side. Changes in MDS-UPDRS-III (motor component of the Movement Disorders Society Unified PD Rating Scale) were not different between the clinically most and least affected body sides. Our data support that the asymmetry in striatal dopaminergic degeneration becomes less prominent in moderate-stage PD. In contrast, during the above period, the asymmetry of motor symptoms was maintained between the clinically most and least affected body sides. Springer Berlin Heidelberg 2020-09-02 2021 /pmc/articles/PMC7880931/ /pubmed/32880071 http://dx.doi.org/10.1007/s00415-020-10204-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Communication Roussakis, Andreas-Antonios Zeng, Zhou Lao-Kaim, Nicholas P. Martin-Bastida, Antonio Piccini, Paola Parkinson’s disease laterality: a (11)C-PE2I PET imaging study |
title | Parkinson’s disease laterality: a (11)C-PE2I PET imaging study |
title_full | Parkinson’s disease laterality: a (11)C-PE2I PET imaging study |
title_fullStr | Parkinson’s disease laterality: a (11)C-PE2I PET imaging study |
title_full_unstemmed | Parkinson’s disease laterality: a (11)C-PE2I PET imaging study |
title_short | Parkinson’s disease laterality: a (11)C-PE2I PET imaging study |
title_sort | parkinson’s disease laterality: a (11)c-pe2i pet imaging study |
topic | Original Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880931/ https://www.ncbi.nlm.nih.gov/pubmed/32880071 http://dx.doi.org/10.1007/s00415-020-10204-y |
work_keys_str_mv | AT roussakisandreasantonios parkinsonsdiseaselateralitya11cpe2ipetimagingstudy AT zengzhou parkinsonsdiseaselateralitya11cpe2ipetimagingstudy AT laokaimnicholasp parkinsonsdiseaselateralitya11cpe2ipetimagingstudy AT martinbastidaantonio parkinsonsdiseaselateralitya11cpe2ipetimagingstudy AT piccinipaola parkinsonsdiseaselateralitya11cpe2ipetimagingstudy AT parkinsonsdiseaselateralitya11cpe2ipetimagingstudy |